Date: 2015-05-14
Type of information: Resignation
Compound:
Company: Pfizer (USA - NY)
Therapeutic area:
Type agreement:
Action mechanism:
Disease:
Details: * On May 14, 2015, Pfizer announced that Director Marc Tessier-Lavigne, Ph.D. has decided to step down from its Board of Directors on May 14, 2015. His decision is coincident with the launch of Denali, a new biotechnology company focused on developing effective therapies for neurodegenerative diseases. Dr. Tessier-Lavigne is a co-founder of Denali, and he will serve as the chairman of the company. Dr. Tessier-Lavigne was appointed to Pfizer’s board of directors in December 2011, and most recently served as a member of the Regulatory and Compliance Committee and Science and Technology Committee.
Financial terms:
Latest news:
